RBC Capital Reiterates Outperform on Verastem, Maintains $13 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has reiterated an Outperform rating on Verastem (NASDAQ:VSTM) and maintained a price target of $13.
October 18, 2024 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its Outperform rating for Verastem, maintaining a price target of $13, indicating confidence in the company's potential for growth.
The reiteration of an Outperform rating and a maintained price target of $13 by RBC Capital suggests a positive outlook for Verastem. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100